Document is current
Any future updates will be listed below
-
Authors
Ohashi, Kayo Egoshi
Fukuhara, Suguru https://orcid.org/0000-0002-2423-9978
Maeshima, Akiko Miyagi
Shibata, Maki
Makino, Haruhi
Hattori, Daiki
Sasaki, Hirokazu
Makita, Shinichi
Iwaki, Noriko
Munakata, Wataru
Fukuda, Takahiro
Ando, Miki
Izutsu, Koji
- License Information
-
More Information
Article History
Received: 14 July 2025
Revised: 9 October 2025
Accepted: 21 October 2025
First Online: 31 October 2025
Declarations
:
: S.F. has received honoraria from Janssen, Ono, BeiGene, Nihon Shinyaku, Otsuka, Chugai, and AstraZeneca; has received grants or funding from Chugai and LOXO Oncology. D.H. has received honoraria from Chugai and Abbvie. M.W. has received honoraria from Chugai; has received grants or funding from Ono, Chugai, and Genmab. K.I. has received honoraria from MSD, AstraZeneca, Abbvie, Bristol Myers Squibb, Novartis, Yakult, Kyowa Kirin, Chugai, Beigene, Genmab, Otsuka, Ono, Mitsubishi Tanabe, Eisai, Symbio, Takeda, Zenyaku, Carna Biosciences, and Nihon Shinyaku; has received grants or funding from Ono, MSD, AstraZeneca, Abbvie, Incyte, Bristol Myers Squibb, Novartis, Bayer, Pfizer, Janssen, Yakult, Kyowa Kirin, Daiichi Sankyo, Chugai, Beigene, Genmab, LOXO Oncology, Otsuka, Regeneron, and Gilead. All other authors declare no conflicts of interest.
